Chemical Structure : Rapavir
Catalog No.: PC-24441Not For Human Use, Lab Use Only.
Rapavir (JH-B10) is a novel inhibitor of sodium taurocholate cotransporting polypeptide (NTCP) with potent anti-HBV efficacy, shows inhibitory activity against both TCA-d4 uptake and HBV infection with IC50 of 1.8 nM (TCA-d4), 63 nM (HBeAg), and 22 nM (HBV 3.5-kb RNA), respectively.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Rapavir (JH-B10) is a novel inhibitor of sodium taurocholate cotransporting polypeptide (NTCP) with potent anti-HBV efficacy, shows inhibitory activity against both TCA-d4 uptake and HBV infection with IC50 of 1.8 nM (TCA-d4), 63 nM (HBeAg), and 22 nM (HBV 3.5-kb RNA), respectively.
The inhibitory effect of rapavir is FKBP12-independent.
Rapavir significantly reduced intracellular HBV cccDNA and HBV RNA, along with extracellular HBeAg and HBsAg, in a concentration-dependent manner, exerts its antiviral effect during the HBV infection phase by directly blocking NTCP, rather than impacting the viral replication process.
Rapavir (2 mg/kg body weight, i.p.) demonstrated the robust anti-HBV activity in humanized liver-chimeric mice.
M.Wt | ||
Formula | ||
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright